CDK4/6 inhibitor ribociclib and doxorubicin combination treatment inhibits breast cancer bone metastasis and enhances T-cell targeted therapy. - Su X; Kobayashi T; Xiang J; Xu Y; Shajahan-Haq AN; Mardani M; Noordeen S; O'Donnell K; Kwakwa KA; Guan D; Fox GC; Fontana F; et al. (Journal of bone oncology, 2026)